Upstate Active Clinical Trials

Study Title:

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy-Induced Neuropathic Pain

What is the purpose of the study? (in Layman's terms, please describe the study)

Treatment of Chemotherapy-Induced Neuropathic pain

Upstate Institutional Review Board (IRB) Number:

1993004

Study/Protocol ID:

TTX-CINP-202

Study Phase:

Phase 2

Patient Age Group:

Adults

Principal Investigator:

Mary J Cunningham, MD

What is involved if I participate?

• How long is the study?
  Screening, Active Tx (4 days) and Follow-up in total of 17 weeks
• Is transportation provided or reimbursed?
  Yes
• Is parking provided or reimbursed?
  Yes
• What tests and procedures are involved?
  Chemistries, CBC w/diff, Urinalysis, Urine drug screen

Where will the study take place?

Madison-Irving GYN and Cancer Center

Other Information:

N/A

ClinicalTrials.Gov ID:

NCT05359133

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Sarah Clark, BS
Phone: 315-464-8276
Email: [email protected]

Return to Previous Page || Search Again